{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T07:01:19Z","timestamp":1773212479900,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,10,15]],"date-time":"2015-10-15T00:00:00Z","timestamp":1444867200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Unfallchirurg"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1007\/s00113-015-0085-9","type":"journal-article","created":{"date-parts":[[2015,10,15]],"date-time":"2015-10-15T14:06:50Z","timestamp":1444918010000},"page":"925-932","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Regulation des Knochenstoffwechsels bei Osteoporose","Regulation of bone metabolism in osteoporosis"],"prefix":"10.1007","volume":"118","author":[{"given":"F.","family":"Jakob","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Genest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Baron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Stumpf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rudert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Seefried","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,15]]},"reference":[{"key":"85_CR1","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.beem.2014.07.003","volume":"28","author":"NM Appelman-Dijkstra","year":"2014","unstructured":"Appelman-Dijkstra NM, Papapoulos SE (2014) Novel approaches to the treatment of osteoporosis. Best Pract Res Clin Endocrinol Metab 28:843\u2013857","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"85_CR2","doi-asserted-by":"crossref","first-page":"e45142","DOI":"10.1371\/journal.pone.0045142","volume":"7","author":"P Benisch","year":"2012","unstructured":"Benisch P, Schilling T, Klein-Hitpass L, Frey SP, Seefried L, Raaijmakers N, Krug M, Regensburger M, Zeck S, Schinke T et al (2012) The transcriptional profile of mesenchymal stem cell populations in primary osteoporosis is distinct and shows overexpression of osteogenic inhibitors. PloS One 7:e45142","journal-title":"PloS One"},{"key":"85_CR3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00198-014-2944-6","volume":"26","author":"HG Bone","year":"2015","unstructured":"Bone HG, Dempster DW, Eisman JA, Greenspan SL, McClung MR, Nakamura T, Papapoulos S, Shih WJ, Rybak-Feiglin A, Santora AC et al (2015) Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the long-term odanacatib fracture trial. Osteoporos Int 26:699\u2013712","journal-title":"Osteoporos Int"},{"key":"85_CR4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1759720X15580903","volume":"7","author":"RD Chapurlat","year":"2015","unstructured":"Chapurlat RD (2015) Odanacatib: a review of its potential in the management of osteoporosis in postmenopausal women. Ther Adv Musculoskelet Dis 7:103\u2013109","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"85_CR5","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.2106\/JBJS.M.01096","volume":"96","author":"JT Compton","year":"2014","unstructured":"Compton JT, Lee FY (2014) A review of osteocyte function and the emerging importance of sclerostin. J Bone Joint Surg Am 96:1659\u20131668","journal-title":"J Bone Joint Surg Am"},{"key":"85_CR6","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/1043-2760(92)90032-V","volume":"3","author":"C Cooper","year":"1992","unstructured":"Cooper C, Melton LJ 3rd (1992) Epidemiology of osteoporosis. Trends Endocrinol Metab 3:224\u2013229","journal-title":"Trends Endocrinol Metab"},{"key":"85_CR7","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrrheum.2011.77","volume":"7","author":"AG Costa","year":"2011","unstructured":"Costa AG, Cusano NE, Silva BC, Cremers S, Bilezikian JP (2011) Cathepsin K: its skeletal actions and role as a therapeutic target in osteoporosis. Nat Rev Rheumatol 7:447\u2013456","journal-title":"Nat Rev Rheumatol"},{"key":"85_CR8","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"SR Cummings","year":"2009","unstructured":"Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, Delmas P, Zoog HB, Austin M, Wang A et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361:756\u2013765","journal-title":"N Engl J Med"},{"key":"85_CR9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.scr.2015.06.008","volume":"15","author":"R Ebert","year":"2015","unstructured":"Ebert R, Benisch P, Krug M, Zeck S, Meissner-Weigl J, Steinert A, Rauner M, Hofbauer L, Jakob F (2015) Acute phase serum amyloid A induces proinflammatory cytokines and mineralization via toll-like receptor 4 in mesenchymal stem cells. Stem Cell Res 15:231\u2013239","journal-title":"Stem Cell Res"},{"key":"85_CR10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/1476-4598-13-265","volume":"13","author":"R Ebert","year":"2014","unstructured":"Ebert R, Meissner-Weigl J, Zeck S, Maatta J, Auriola S, Coimbra de Sousa S, Mentrup B, Graser S, Rachner TD, Hofbauer LC et al (2014) Probenecid as a sensitizer of bisphosphonate-mediated effects in breast cancer cells. Mol Cancer 13:265","journal-title":"Mol Cancer"},{"key":"85_CR11","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/jbmr.212","volume":"26","author":"JA Eisman","year":"2011","unstructured":"Eisman JA, Bone HG, Hosking DJ, McClung MR, Reid IR, Rizzoli R, Resch H, Verbruggen N, Hustad CM, DaSilva C et al (2011) Odanacatib in the treatment of postmenopausal women with low bone mineral density: three-year continued therapy and resolution of effect. J Bone Miner Res 26:242\u2013251","journal-title":"J Bone Miner Res"},{"key":"85_CR12","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jbiomech.2015.01.032","volume":"48","author":"JR Geissler","year":"2015","unstructured":"Geissler JR, Bajaj D, Fritton JC (2015) American society of biomechanics journal of biomechanics award 2013: cortical bone tissue mechanical quality and biological mechanisms possibly underlying atypical fractures. J Biomech 48:883\u2013894","journal-title":"J Biomech"},{"key":"85_CR13","first-page":"52","volume":"110","author":"P Hadji","year":"2013","unstructured":"Hadji P, Klein S, Gothe H, Haussler B, Kless T, Schmidt T, Steinle T, Verheyen F, Linder R (2013) The epidemiology of osteoporosis \u2013 Bone Evaluation Study (BEST): an analysis of routine health insurance data. Dtsch Arztebl Int 110:52\u201357","journal-title":"Dtsch Arztebl Int"},{"key":"85_CR14","doi-asserted-by":"crossref","first-page":"953241","DOI":"10.1155\/2015\/953241","volume":"2015","author":"M Halfon","year":"2015","unstructured":"Halfon M, Phan O, Teta D (2015) Vitamin D: a review on its effects on muscle strength, the risk of fall, and frailty. BioMed Res Int 2015:953241","journal-title":"BioMed Res Int"},{"key":"85_CR15","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S2213-8587(13)70203-1","volume":"2","author":"LC Hofbauer","year":"2014","unstructured":"Hofbauer LC, Rachner TD, Coleman RE, Jakob F (2014) Endocrine aspects of bone metastases. Lancet Diabetes Endocrinol 2:500\u2013512","journal-title":"Lancet Diabetes Endocrinol"},{"key":"85_CR16","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00198-011-1671-5","volume":"23","author":"C Holroyd","year":"2012","unstructured":"Holroyd C, Harvey N, Dennison E, Cooper C (2012) Epigenetic influences in the developmental origins of osteoporosis. Osteoporos Int 23:401\u2013410","journal-title":"Osteoporos Int"},{"key":"85_CR17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bbalip.2012.06.002","volume":"1831","author":"M Ishii","year":"2013","unstructured":"Ishii M, Kikuta J (2013) Sphingosine-1-phosphate signaling controlling osteoclasts and bone homeostasis. Biochim Biophys Acta 1831:223\u2013227","journal-title":"Biochim Biophys Acta"},{"key":"85_CR18","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00108-014-3468-z","volume":"55","author":"F Jakob","year":"2014","unstructured":"Jakob F, Seefried L, Schwab M (2014) [Age and osteoporosis. Effects of aging on osteoporosis, the diagnostics and therapy]. Internist (Berl) 55:755\u2013761","journal-title":"Internist (Berl)"},{"issue":"2","key":"85_CR19","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.bone.2012.10.013","volume":"54","author":"J Klein-Nulend","year":"2012","unstructured":"Klein-Nulend J, Bakker AD, Bacabac RG, Vatsa A, Weinbaum S (2013) Mechanosensation and transduction in osteocytes. Bone 54(2):182\u2013190","journal-title":"Bone"},{"key":"85_CR20","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1002\/jbmr.1695","volume":"27","author":"B Langdahl","year":"2012","unstructured":"Langdahl B, Binkley N, Bone H, Gilchrist N, Resch H, Rodriguez Portales J, Denker A, Lombardi A, Le Bailly De Tilleghem C, Dasilva C et al (2012) Odanacatib in the treatment of postmenopausal women with low bone mineral density: five years of continued therapy in a phase 2 study. J Bone Miner Res 27:2251\u20132258","journal-title":"J Bone Miner Res"},{"key":"85_CR21","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s11914-012-0109-0","volume":"10","author":"PJ Marie","year":"2012","unstructured":"Marie PJ (2012) Signaling pathways affecting skeletal health. Curr Osteoporos Rep 10:190\u2013198","journal-title":"Curr Osteoporos Rep"},{"key":"85_CR22","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1305224","volume":"370","author":"MR McClung","year":"2014","unstructured":"McClung MR, Grauer A, Boonen S, Bolognese MA, Brown JP, Diez-Perez A, Langdahl BL, Reginster JY, Zanchetta JR, Wasserman SM et al (2014) Romosozumab in postmenopausal women with low bone mineral density. N Engl J Med 370:412\u2013420","journal-title":"N Engl J Med"},{"key":"85_CR23","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1002\/jbmr.1659","volume":"27","author":"A Moayyeri","year":"2012","unstructured":"Moayyeri A, Hammond CJ, Hart DJ, Spector TD (2012) Effects of age on genetic influence on bone loss over 17 years in women: the Healthy Ageing Twin Study (HATS). J Bone Miner Res 27:2170\u20132178","journal-title":"J Bone Miner Res"},{"key":"85_CR24","doi-asserted-by":"crossref","unstructured":"Nagy V, Penninger JM (2015) The rankl-rank story. Gerontology","DOI":"10.1159\/000371845"},{"key":"85_CR25","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/jbmr.1866","volume":"28","author":"H Nakamura","year":"2013","unstructured":"Nakamura H, Aoki K, Masuda W, Alles N, Nagano K, Fukushima H, Osawa K, Yasuda H, Nakamura I, Mikuni-Takagaki Y et al (2013) Disruption of NF-kappaB1 prevents bone loss caused by mechanical unloading. J Bone Miner Res 28:1457\u20131467","journal-title":"J Bone Miner Res"},{"key":"85_CR26","doi-asserted-by":"crossref","unstructured":"Papapoulos S, Lippuner K, Roux C, Lin CJ, Kendler DL, Lewiecki EM, Brandi ML, Czerwi\u0144ski E, Franek E, Lakatos P, Mautalen C, Minisola S, Reginster JY, Jensen S, Daizadeh NS, Wang A, Gavin M, Libanati C, Wagman RB, Bone HG (2015) The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM extension study. Osteoporos Int [Epubahead of print]. PubMed PMID: 26202488","DOI":"10.1007\/s00198-015-3234-7"},{"key":"85_CR27","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S0140-6736(10)62349-5","volume":"377","author":"TD Rachner","year":"2011","unstructured":"Rachner TD, Khosla S, Hofbauer LC (2011) Osteoporosis: now and the future. Lancet 377:1276\u20131287","journal-title":"Lancet"},{"key":"85_CR28","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.actbio.2014.11.021","volume":"13","author":"H Razi","year":"2015","unstructured":"Razi H, Birkhold AI, Zaslansky P, Weinkamer R, Duda GN, Willie BM, Checa S (2015) Skeletal maturity leads to a reduction in the strain magnitudes induced within the bone: a murine tibia study. Acta biomaterialia 13:301\u2013310","journal-title":"Acta biomaterialia"},{"key":"85_CR29","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nrg3228","volume":"13","author":"JB Richards","year":"2012","unstructured":"Richards JB, Zheng HF, Spector TD (2012) Genetics of osteoporosis from genome-wide association studies: advances and challenges. Nat Rev Genet 13:576\u2013588","journal-title":"Nat Rev Genet"},{"key":"85_CR30","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1055\/s-2003-40935","volume":"128","author":"N Schutze","year":"2003","unstructured":"Schutze N, Ebert R, Paunescu K, Jakob F (2003) [Genetics of osteoporosis]. Dtsch Med Wochenschr 128:1609\u20131614","journal-title":"Dtsch Med Wochenschr"},{"key":"85_CR31","first-page":"565","volume":"7","author":"AD Shah","year":"2015","unstructured":"Shah AD, Shoback D, Lewiecki EM (2015) Sclerostin inhibition: a novel therapeutic approach in the treatment of osteoporosis. Int J Women\u02bcs Health 7:565\u2013580","journal-title":"Int J Women\u02bcs Health"},{"key":"85_CR32","first-page":"41","volume":"6","author":"NA Sims","year":"2015","unstructured":"Sims NA, Martin TJ (2015) Coupling signals between the osteoclast and osteoblast: how are messages transmitted between these temporary visitors to the bone surface? Front Endocrinol 6:41","journal-title":"Front Endocrinol"},{"key":"85_CR33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11657-011-0060-1","volume":"6","author":"O Strom","year":"2011","unstructured":"Strom O, Borgstrom F, Kanis JA, Compston J, Cooper C, McCloskey EV, Jonsson B (2011) Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 6:59\u2013155","journal-title":"Arch Osteoporos"},{"key":"85_CR34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11657-014-0187-y","volume":"9","author":"A Svedbom","year":"2014","unstructured":"Svedbom A, Ivergard M, Hernlund E, Rizzoli R, Kanis JA (2014) Epidemiology and economic burden of osteoporosis in Switzerland. Arch Osteoporos 9:187","journal-title":"Arch Osteoporos"},{"key":"85_CR35","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/bonekey.2013.183","volume":"2","author":"A Teti","year":"2013","unstructured":"Teti A (2013) Mechanisms of osteoclast-dependent bone formation. Bonekey Rep 2:449","journal-title":"Bonekey Rep"},{"key":"85_CR36","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s11914-005-0015-9","volume":"3","author":"AD Woolf","year":"2005","unstructured":"Woolf AD, Pfleger B (2005) Burden of osteoporosis and fractures in developing countries. Curr Osteoporos Rep 3:84\u201391","journal-title":"Curr Osteoporos Rep"},{"key":"85_CR37","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/jbmr.2461","volume":"30","author":"TA Yorgan","year":"2015","unstructured":"Yorgan TA, Peters S, Jeschke A, Benisch P, Jakob F, Amling M, Schinke T (2015) The anti-osteoanabolic function of sclerostin is blunted in mice carrying a high bone mass mutation of lrp5. J Bone Miner Res 30:1175\u20131183","journal-title":"J Bone Miner Res"},{"key":"85_CR38","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1517\/17425255.2015.1000860","volume":"11","author":"S Zaheer","year":"2015","unstructured":"Zaheer S, LeBoff M, Lewiecki EM (2015) Denosumab for the treatment of osteoporosis. Expert Opin Drug Metab Toxicol 11:461\u2013470","journal-title":"Expert Opin Drug Metab Toxicol"}],"container-title":["Der Unfallchirurg"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00113-015-0085-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00113-015-0085-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00113-015-0085-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T04:49:39Z","timestamp":1558586979000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00113-015-0085-9"}},"subtitle":["Neuartige Osteoporosemedikamente in der Entwicklung","Novel drugs for osteoporosis in development"],"short-title":[],"issued":{"date-parts":[[2015,10,15]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["85"],"URL":"https:\/\/doi.org\/10.1007\/s00113-015-0085-9","relation":{},"ISSN":["0177-5537","1433-044X"],"issn-type":[{"value":"0177-5537","type":"print"},{"value":"1433-044X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,15]]}}}